Core needle breast biopsy safe for patients taking blood thinners

October 1, 2008

It is safe to take anticoagulants (blood thinners) before core needle breast biopsies, according to a study performed at the Elizabeth Wende Breast Clinic in Rochester, NY. Core needle biopsies are offered as an alternative to surgical biopsy when a tissue sample of an irregular area in the breast is found by mammogram or sonogram. "They are safer than surgical procedures, require fewer anesthetics, and are accurate," according to Patricia Somerville, MD, lead author of the study.

The study included 200 women who were taking anticoagulants (blood thinners) and 855 women who were not. Adverse reactions, lumps and bruises, after a woman's core needle biopsy were recorded. Results showed that lumps or bruising occurred in 34% of women who were taking blood thinners and 26.5% of women who were not taking them.

"Our study demonstrates that it is safe to perform core needle biopsies on patients taking aspirin and warfarin (another name for coumadin). Patients can remain on their medications and avoid surgical biopsy if the lesion is benign," said Dr. Somerville.

Source: American Roentgen Ray Society

Explore further: Needle biopsies for noninvasive breast cancer: Routine analysis wastes millions

Related Stories

Needle biopsies for noninvasive breast cancer: Routine analysis wastes millions

August 9, 2016
For patients with the most common type of noninvasive breast cancer, routine testing for estrogen and progesterone receptors in tissue taken at the first "needle" biopsy is both unnecessary and wasteful, according to results ...

Taking stock: Where does Europe stand in the elimination of hepatitis B and C?

March 2, 2017
In 2016, a regional action plan for Europe contributing to the implementation of the global viral hepatitis elimination strategy was developed by the WHO Regional Office for Europe. In an article published today in Eurosurveillance, ...

Targeted antibody, immune checkpoint blocker rein in follicular lymphoma

December 11, 2013
One drug attacks tumor cells directly, the other treats the immune system by taking the brakes off T cell response. Together, they put half of the patients with relapsed follicular lymphoma into complete remission in a phase ...

Molecular and protein markers discovered for liver transplant failure from hepatitis C

August 16, 2012
Researchers have discovered molecular and protein signatures that predict rapid onset of liver damage in hepatitis C patients following a liver transplant. The markers appeared soon after transplant and well before clinical ...

Creating a 'computer-simulated' virtual patient to train clinicians

August 30, 2013
In the future, should you need complicated surgery, the surgeon will be able to prepare and even practice for the procedure on a virtual simulation of your own body or body part that needs attention.

'Zero tolerance' Sweden leaves heavy drug users behind

April 10, 2014
Sweden boasts one of Europe's lowest consumption of recreational drugs, but the same strict policy authorities consider key to success could also be pushing up the number of drug-related deaths.

Recommended for you

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.